Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

for IMAGe Group

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/ recommendations that can be adapted to the Indian Scenario.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalIndian Journal of Hematology and Blood Transfusion
DOIs
StateAccepted/In press - Jan 2 2017

Fingerprint

Multiple Myeloma
India
Guidelines
Drug Approval
Internationality
Practice Management
Disease Management
Plasma Cells
Physicians
Research
Therapeutics

Keywords

  • Consensus
  • Indian scenario
  • Multiple myeloma
  • Plasma cell dyscrasia

ASJC Scopus subject areas

  • Hematology

Cite this

@article{3fac672841be484bb6ffb94805120147,
title = "Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference",
abstract = "The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/ recommendations that can be adapted to the Indian Scenario.",
keywords = "Consensus, Indian scenario, Multiple myeloma, Plasma cell dyscrasia",
author = "{for IMAGe Group} and Uday Yanamandra and Navin Khattry and Kumar, {Shaji K} and Noopur Raje and Arihant Jain and Sundar Jagannath and Hari Menon and Lalit Kumar and Neelam Varma and Subhash Varma and Tapan Saikia and Pankaj Malhotra and Abhay Bhave and Ajay Sharma and Tripathi, {A. K.} and Alka Khadwal and Anil Aribandi and Anita Ramesh and Ashish Dixit and Devasia, {Anup J.} and Charu Batra and Chezhian Subash and Dharma Choudhary and Dinesh Bhurani and Deepesh Lad and Farah Jijina and Gaurav Prakash and Ganesh Jaishetwar and Harshit Khurana and Hemant Malhotra and Kohli, {H. S.} and Ian Pinto and Javid Rasool and Jatin Sarin and Jina Bhattacharyya and Singh, {Col Jasjit} and Babu, {K. Govind} and K. Pavithran and Kannan Subramanian and John, {M. Joseph} and Sachdeva, {Man Updesh Singh} and Maitreyee Bhattacharyya and Agarwal, {M. B.} and Manju Sengar and Narender Kumar and Nitin Sood and Prantar Chakravarti and Subramanian, {P. G.} and Prashant Sharma and Prashant Tembhare",
year = "2017",
month = "1",
day = "2",
doi = "10.1007/s12288-016-0773-9",
language = "English (US)",
pages = "1--7",
journal = "Indian Journal of Hematology and Blood Transfusion",
issn = "0971-4502",
publisher = "Springer India",

}

TY - JOUR

T1 - Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

AU - for IMAGe Group

AU - Yanamandra, Uday

AU - Khattry, Navin

AU - Kumar, Shaji K

AU - Raje, Noopur

AU - Jain, Arihant

AU - Jagannath, Sundar

AU - Menon, Hari

AU - Kumar, Lalit

AU - Varma, Neelam

AU - Varma, Subhash

AU - Saikia, Tapan

AU - Malhotra, Pankaj

AU - Bhave, Abhay

AU - Sharma, Ajay

AU - Tripathi, A. K.

AU - Khadwal, Alka

AU - Aribandi, Anil

AU - Ramesh, Anita

AU - Dixit, Ashish

AU - Devasia, Anup J.

AU - Batra, Charu

AU - Subash, Chezhian

AU - Choudhary, Dharma

AU - Bhurani, Dinesh

AU - Lad, Deepesh

AU - Jijina, Farah

AU - Prakash, Gaurav

AU - Jaishetwar, Ganesh

AU - Khurana, Harshit

AU - Malhotra, Hemant

AU - Kohli, H. S.

AU - Pinto, Ian

AU - Rasool, Javid

AU - Sarin, Jatin

AU - Bhattacharyya, Jina

AU - Singh, Col Jasjit

AU - Babu, K. Govind

AU - Pavithran, K.

AU - Subramanian, Kannan

AU - John, M. Joseph

AU - Sachdeva, Man Updesh Singh

AU - Bhattacharyya, Maitreyee

AU - Agarwal, M. B.

AU - Sengar, Manju

AU - Kumar, Narender

AU - Sood, Nitin

AU - Chakravarti, Prantar

AU - Subramanian, P. G.

AU - Sharma, Prashant

AU - Tembhare, Prashant

PY - 2017/1/2

Y1 - 2017/1/2

N2 - The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/ recommendations that can be adapted to the Indian Scenario.

AB - The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/ recommendations that can be adapted to the Indian Scenario.

KW - Consensus

KW - Indian scenario

KW - Multiple myeloma

KW - Plasma cell dyscrasia

UR - http://www.scopus.com/inward/record.url?scp=85007566310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007566310&partnerID=8YFLogxK

U2 - 10.1007/s12288-016-0773-9

DO - 10.1007/s12288-016-0773-9

M3 - Article

AN - SCOPUS:85007566310

SP - 1

EP - 7

JO - Indian Journal of Hematology and Blood Transfusion

JF - Indian Journal of Hematology and Blood Transfusion

SN - 0971-4502

ER -